IN10018

· InventisBio Co., Ltd

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for IN10018, covering 2025-04-08 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours [Phase 1, Phase 2]